CoreRx, Inc. announces the appointment of Dan Dobry as chief strategy officer and a member of CoreRx’s executive leadership team. Dobry will report to CoreRx’s chief executive officer, Ajay Damani.
Dobry brings to CoreRx twenty-five years of experience as a global CDMO business leader and drug delivery innovator. Early in his career, he contributed to process and formulation development, particle engineering. and materials science innovations, resulting in more than fifteen patents. His experience in the pharma services industry, manufacturing science and technology, product development, alliance management, and in corporate development will be a valued addition to the CoreRx team. Previously, Dobry held leadership roles in commercial development at Lonza, strategic alliance management at Capsugel, and as the vice president of engineering for Bend Research, Inc.
In his role as chief strategy officer, Dobry will oversee CoreRx’s strategy and corporate development functions. He will work closely with CoreRx’s executive leadership team and board of directors in evaluating, developing, and executing CoreRx’s strategic growth initiatives.
“I’m thrilled to join CoreRx at this stage in its journey,” says Dobry.